UBS Group’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $45.3M | Buy |
|
|||||
|
2025
Q2 | $8.67M | Buy |
|
|||||
|
2025
Q1 | $1.44M | Buy |
|
|||||
|
2024
Q4 | $1.26M | Buy |
|
|||||
|
2024
Q3 | $63.2K | Buy |
|
|||||
|
2024
Q2 | $17.5K | Buy |
|
|||||
|
2024
Q1 | $4.32K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $0 | Sell |
|
|||||
|
2022
Q1 | $1K | Buy |
|
|||||
|
2021
Q4 | $0 | Hold |
|
|||||
|
2021
Q3 | $0 | Sell |
|
|||||
|
2021
Q2 | $12K | Sell |
|
|||||
|
2021
Q1 | $62K | Sell |
|
|||||
|
2020
Q4 | $50K | Sell |
|
|||||
|
2020
Q3 | $440K | Buy |
|
|||||
|
2020
Q2 | $520K | Buy |
|
|||||
|
2020
Q1 | $87K | Buy |
|
|||||
|
2019
Q4 | $10K | Sell |
|
|||||
|
2019
Q3 | $18K | Buy |
|
|||||
|
2019
Q2 | $14K | Sell |
|
|||||
|
2019
Q1 | $29K | Buy |
|
|||||
|
2018
Q4 | $22K | Buy |
|
|||||
|
2018
Q3 | $20K | Sell |
|
|||||
|
2018
Q2 | $38K | Buy |
|
|||||
|
2018
Q1 | $15K | Buy |
|
|||||
|
2017
Q4 | $10K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $1K | Sell |
|
|||||
|
2017
Q1 | $10K | Sell |
|
|||||
|
2016
Q4 | $74K | Buy |
|
|||||
|
2016
Q3 | $31K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $12K | Buy |
|
|||||
|
2015
Q2 | $0 | Buy |
|